Sunday, December 11, 2005


Hepatitis C Information - MIGENIX Reports Second Quarter Results


MIGENIX Reports Second Quarter Results
BC Technology - study in treatment naive and interferon-intolerant genotype 1 HCV patients was completed in September 2005 with a total

Baseline Factors Identify HIV-HCV Coinfected Patients Prone to Hematological Toxicity during Anti-HCV Therapy
HIV and Hepatitis.com - This was a multicentre, prospective, observational study conducted at 11 hospitals in Spain during the period 2002-2003. One-hundred and forty-two HIV/HCV-coinfected patients received peginterferon-alpha2a plus ribavirin.

Severe Impairment In Quality Of Life In Hiv+ With Hcv But Not With Hbv
National AIDS Treatment Advocacy Project - Tillmann, University Leipzig, Leipzig, Thorsten Kaiser, Universita t Leipzig, Leipzig, Michael P. Manns, Reinhold E. IMPAIRMENT IN QUALITY OF LIFE IN HIV+ WITH HCV BUT NOT WITH HBV Conference Reports for NATAP AASLD OF LIFE IN HIV+ WITH HCV BUT NOT WITH HBV Reported by